Form 8-K · Current Report · Filed 2024-10-17
Elevance Health Reports Q3 2024 Financial Results
Elevance Health, Inc. reported a 5.3% increase in operating revenue to $44.7 billion for the third quarter of 2024. The company's adjusted operating gain was $2.4 billion, with an adjusted diluted EPS of $8.37. The results were impacted by higher premium yields, membership attrition in the Medicaid business, and operational efficiencies. Elevance Health also declared a fourth quarter dividend of $1.63 per share and authorized an $8.0 billion increase to its common stock repurchase program.
- Filer
- Elevance Health Inc. ELV · NYSE
- Filed
- Accession
- 0001156039-24-000119
- CIK
- 0001156039
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Results of Operations and Financial Condition
Financial Statements and Exhibits
Market reaction
Close before filing
$496.96
Next session
-13.3%
Since filing
-24.4%
Latest close
$375.84
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from ELV reporting the same item, with the next session's move:
Exhibits (1)
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Never miss another ELV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.